logo

WST

West Pharmaceutical·NYSE
--
--(--)
--
--(--)

WST fundamentals

West Pharmaceutical (WST) expects to report earnings on Feb 12, 2026, with estimated revenue of 795.72M (YoY +6.27%), and EPS at 1.836 (YoY +0.88%).
Revenue estimate / YoY
795.72M
+6.27%
EPS estimate / YoY
1.836
+0.88%
Report date
Feb 12, 2026
Earnings Call
8:00 AM on Feb 12, 2026
Meeting link.
EPS
Revenue

Revenue & Expenses

WST has released its 2025 Q3 earnings report, with revenue of 804.60M, reflecting a YoY change of 7.73%, and net profit of 140.00M, showing a YoY change of 2.94%. The Sankey diagram below clearly presents WST's revenue sources and cost distribution.

Key Indicators

West Pharmaceutical (WST) key financial stats and ratios, covering profitability, financial health, and leverage.
West Pharmaceutical (WST)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
West Pharmaceutical (WST)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
West Pharmaceutical (WST)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does West Pharmaceutical (WST) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track West Pharmaceutical (WST) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield